Onpode
Cover art for New survey: nearly one-third of Americans aspire to extreme longevity—what's driving the shift?

New survey: nearly one-third of Americans aspire to extreme longevity—what's driving the shift?

July 5, 2026 · 8 min

Michael C. Vincent

Surveys show 29% to 77% of Americans want to reach 100, with the average ideal lifespan at 91 versus a current life expectancy of 78. Yet over 40% of Americans under 65 doubt they can afford extreme longevity, and U.S. retirement infrastructure was never designed for a quadrupled centenarian population.

A recent Pew Research Center survey of 8,750 U.S. adults found that Americans would ideally like to live to an average age of 91, with 29% specifically hoping to reach age 100 — notably higher than the current U.S. life expectancy at birth of approximately 78 years.

0:008:06
Make your own on Onpode

Describe any topic. Hear it in minutes.

More Onpode episodes on Longevity

About this episode

Nearly a third of Americans say they want to live to 100 — or maybe three-quarters do, depending on which survey you read. The range across credible polls is 48 percentage points wide, which tells you something important: we don't actually have a clear picture of what Americans want from a long life. We just know they want more of it than they're likely to get, and more than they've prepared for. This episode works through what those numbers really mean. The average ideal lifespan Americans name is 91. Current life expectancy sits around 78. That 13-year gap exists before anyone even starts talking about reaching 100 — and the financial gap is just as real. More than 40% of Americans under 65 already doubt they could afford extreme longevity. The episode also pulls apart a distinction the surveys consistently ignore: healthspan versus lifespan. The science cares about the difference. The supplement industry does not. And as personalized longevity medicine grows more sophisticated — genomics, biomarker tracking, AI-driven care — it's sorting itself by who can afford it, which raises questions that researchers like Daniel Promislow at Tufts are starting to ask out loud. Underneath all of it is one clear finding: the aspiration is accelerating, and the infrastructure — medical, financial, social — is standing still. That gap is the story the surveys can't quite tell.

Frequently asked

What percentage of Americans want to live to 100?

Surveys show a wide range: a Pew Research Center survey of 8,750 U.S. adults found 29% want to reach 100, while a Stanford Center on Longevity and Time magazine survey found 77%. Corebridge Financial found 54% in 2024 and 49% in 2025. The average American's ideal lifespan is 91 years.

Can Americans actually afford to live to 100?

Most Americans cannot currently afford to live to 100. In the Stanford and Time magazine survey, more than 40% of respondents under 65 said they doubted they would have sufficient financial resources to reach that age. U.S. retirement and long-term care systems were built around a 78-year life expectancy, not a quadrupled centenarian population.

What is the difference between healthspan and lifespan in longevity research?

Lifespan is the total number of years lived; healthspan is the years spent fully functional and independent. Stanford geneticist Anne Brunet and the Knight Initiative for Brain Resilience focus on healthy aging pathways rather than simply extending the raw number of years, since a longer life with prolonged decline is not the goal of serious longevity science.

Is the longevity industry trustworthy, or is it mostly hype?

Cardiologist Eric Topol, speaking on NPR's TED Radio Hour, drew a clear line: resistance training, sleep, and vaccines are evidence-backed longevity interventions. Peptides and biohacking products promoted by influencers are not, and Topol called them outright 'grift.' Gerontologist Nir Barzilai adds that genetics can override lifestyle predictions entirely.

Will the U.S. social safety net handle a much larger centenarian population?

Pew Research Center projects the U.S. centenarian population will quadruple. Medicare eligibility ages, Social Security retirement ages, and long-term care funding were all designed around a 78-year life expectancy and are not being restructured at the speed the demographic shift demands. Daniel Promislow of Tufts warns the financial and social consequences have not been seriously addressed.

Grounded in 10 sources
Pathways to Longevity: Science and strategies in pursuit of a longer, healthier life - Harvard Health · health.harvard.edu
Geneticist Anne Brunet explores the science of aging | Stanford Report · news.stanford.edu
Evidence-Based Pathways to Healthy Aging: A Systematic Review ... · pmc.ncbi.nlm.nih.gov
Living to 100: Surprising longevity secrets from centenarians : NPR · npr.org
The expert on 'super aging' breaks down the science — and grift — in anti-aging : NPR · npr.org
Unlocking the Secrets to Living to 100 - TIME · time.com
The potential problems of living longer: Q&A · medicalxpress.com
Living to 120 and Beyond: Americans’ Views on Aging, Medical Advances and Radical Life Extension | Pew Research Center · pewresearch.org
Americans want to live to age 91, on average | Pew Research Center · pewresearch.org
U.S. centenarian population is projected to quadruple over the next ... · pewresearch.org
Read transcript

Michael C. Vincent: Here's something you've probably heard — that Americans don't actually want to live that long, that reaching 100 sounds more like a threat than a gift to most people. The data says otherwise. And then immediately contradicts itself.

Michael C. Vincent: Pew Research Center: 29% want to reach 100. That's from a survey of 8,750 U.S. adults, November 2025. Then you've got Stanford Center on Longevity and Time magazine — 77% want to reach 100. Same country. Close enough in time to be the same cultural moment.

Michael C. Vincent: Forty-eight percentage points apart.

Michael C. Vincent: Corebridge Financial and The Longevity Project ran two waves — 54% in 2024, 49% in 2025 — and in that second wave, half the country called 100 a realistic possibility. So the range across credible surveys goes from less than a third to more than three-quarters.

Michael C. Vincent: What the surveys DO agree on: Americans want more time than they have. Pew found the average ideal lifespan sitting at 91 — and current life expectancy runs about 78. The gap between what people want and what biology delivers is already thirteen years.

Michael C. Vincent: Pew also projects the U.S. centenarian population will quadruple. So the world we're mapping here — it's coming.

Michael C. Vincent: Hold that detail. It matters for everything that follows.

Michael C. Vincent: In the Stanford and Time survey — the one with 77% wanting to reach 100 — more than 40% of respondents under 65 said they doubted they'd have sufficient financial resources to actually get there.

Michael C. Vincent: People are naming 100 as a goal and simultaneously admitting they can't fund it. That's not pessimism. That's a structural crack.

Michael C. Vincent: The aspiration is real. The readiness is not. And that gap — between the life people say they want and the life they've actually prepared for — that's the whole story.

Michael C. Vincent: That gap — it's not just financial.

Michael C. Vincent: The surveys are asking: do you want to live to 100? And people are saying yes. But nobody's asking the harder question — what does 100 actually look like when you get there?

Michael C. Vincent: Longevity researchers have a word for this. Two words, actually. Healthspan versus lifespan.

Michael C. Vincent: Lifespan is the raw number — years on the clock. Healthspan is the years you're actually functional. Present. Moving through the world without someone else managing your calendar and your medications.

Michael C. Vincent: The science knows the difference, even when the surveys don't bother to ask it.

Michael C. Vincent: Anne Brunet — professor of genetics at Stanford School of Medicine — she's been working on the molecular mechanisms of aging, and the framing she uses is not 'how do we add years.' It's healthy aging pathways. The Knight Initiative for Brain Resilience operates in that same lane. The goal isn't a longer decline. It's more time in the part of life that actually resembles living.

Michael C. Vincent: That distinction matters enormously.

Michael C. Vincent: Because the commercial world — the supplements, the peptides, the biohacking influencers — none of them are selling healthspan. They're selling the number.

Michael C. Vincent: Eric Topol — cardiologist, appeared on NPR's TED Radio Hour — he named it plainly. Resistance training, sleep, vaccines: evidence-backed. Peptides, biohacks, whatever the influencer of the week is pushing: grift. His word.

Michael C. Vincent: Grift.

Michael C. Vincent: And into all of this walks Nir Barzilai — gerontologist, president of the Academy of Geroscience — at the Longevity World Forum in Madrid, February 2026, telling the story of a patient named Helen Reichert.

Michael C. Vincent: Helen Reichert lived to 109. She smoked. She ate hamburgers. Chocolate. Beer. The lifestyle optimization crowd would have written her off at fifty.

Michael C. Vincent: She outlived the chart.

Michael C. Vincent: Barzilai isn't saying go smoke and drink beer — that's not the point. The point is that the limits of lifestyle-based longevity prediction are real. Genetics moves in directions the optimization industry doesn't account for. And the industry does not want you thinking about that.

Michael C. Vincent: But here's where it gets genuinely troubling — and honestly, this is the part I keep coming back to.

Michael C. Vincent: The Journal of Medical Internet Research published a piece in June 2026 on the ethics of longevity medicine. Genomics. Biomarker tracking. AI-driven care. The whole personalized longevity apparatus that serious researchers are actually developing.

Michael C. Vincent: Expensive. Primarily accessible to the wealthy.

Michael C. Vincent: Which means the longevity future — if it arrives — does not arrive evenly.

Michael C. Vincent: Daniel Promislow, senior scientist at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts, is asking whether we're actually ready to have that conversation — the financial consequences, the social consequences, the medical consequences of widespread lifespan extension — before we just charge ahead.

Michael C. Vincent: We are not ready.

Michael C. Vincent: The aspiration is widening. The preparation isn't keeping pace. And the science that could actually deliver something real is already sorting itself by who can afford it.

Michael C. Vincent: That's the structural crack I mentioned — and it runs deeper than a funding gap. It runs straight through the story we're telling ourselves about what it even means to want a long life.

Michael C. Vincent: Vox reported it in mid-2026 — the U.S. death rate hit a record low. Life expectancy set to reach a new high. Which sounds like good news. It is good news. But watch what it demands.

Michael C. Vincent: Pew projects the centenarian population will quadruple. Not double. Not grow incrementally. Quadruple. And the Corebridge Financial follow-up from 2025 — the one with 49% of Americans wanting to reach 100 — also found that half the country already believes it's realistically achievable. Half. That is not a fringe aspiration anymore. That is a majority position. Which means the systems built around a 78-year life expectancy are quietly, structurally misaligned with the world that is already forming.

Michael C. Vincent: Think about what those systems are. Medicare eligibility. Social Security's retirement age. Long-term care funding — which barely functions now, for a population far smaller than what's coming. None of it was designed for a quadrupled centenarian baseline. None of it is being redesigned at anything close to the speed the demography demands.

Michael C. Vincent: The aspiration is accelerating and the infrastructure is standing still. Over 40% of Americans under 65 already doubt they can afford to reach 100. That doubt is well-founded. The financial architecture does not exist to absorb this. Not yet. Maybe not ever, if nobody treats it as the emergency it is.

Michael C. Vincent: The honest question — and I don't have a clean answer — is whether the longevity aspiration survives contact with fiscal reality. Whether the 77% who told Stanford and Time they want to reach 100 will still feel that way once the bill arrives. Not just the personal bill. The collective one.

Michael C. Vincent: That is the specific thing to watch. Not whether people will live longer — they will. Whether the policy moves at anything close to the speed the numbers demand. So far… it isn't.

Michael C. Vincent: The surveys will keep coming. A new number every year — 54%, 49%, 77%, 29% — all of them measuring the same thing, really, which is desire. Raw, unexamined desire. And desire is not a plan. It never has been. What none of those numbers can capture is the moment a person actually arrives at 90, or 95, or 100, and discovers the gap between the life they imagined and the life the infrastructure was built to support. That moment is not hypothetical. For a quadrupled centenarian population, it is a scheduled event.

Michael C. Vincent: The aspiration-preparation gap — that is the story inside every survey, every projection, every optimistic headline about record-low death rates. Not whether people want to live to 100. They do. The question is what they find when they get there.